Page 13 - Freeline Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Freeline therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Freeline Therapeutics Today - Breaking & Trending Today

BTIG Research Lowers Freeline Therapeutics (NASDAQ:FRLN) Price Target to $2.00

Freeline Therapeutics (NASDAQ:FRLN – Get Rating) had its price target lowered by BTIG Research from $3.00 to $2.00 in a report published on Thursday, The Fly reports. Other equities analysts also recently issued research reports about the stock. Stifel Nicolaus downgraded shares of Freeline Therapeutics from a buy rating to a hold rating and cut […] ....

Stifel Nicolaus , Acadian Asset Management , Asset Management Gp Ltd , Renaissance Technologies , Thrivent Financial For Lutherans , Freeline Therapeutics Holdings , Freeline Therapeutics , Get Rating , Therapeutics Holdings , Freeline Therapeutics Daily , Nasdaq Frln , Lower Price Target , Btig Research ,

Freeline Therapeutics (NASDAQ:FRLN) PT Lowered to $2.00

Freeline Therapeutics (NASDAQ:FRLN – Get Rating) had its price target decreased by BTIG Research from $3.00 to $2.00 in a research report sent to investors on Thursday, The Fly reports. Other research analysts have also issued reports about the company. Stifel Nicolaus lowered Freeline Therapeutics from a buy rating to a hold rating and decreased […] ....

Stifel Nicolaus , Thrivent Financial For Lutherans , Renaissance Technologies , Freeline Therapeutics Holdings , Hermes Inc , Acadian Asset Management , Freeline Therapeutics , Get Rating , Therapeutics Stock Down , Asset Management , Therapeutics Holdings , Freeline Therapeutics Daily , Nasdaq Frln , Lower Price Target , Btig Research ,

Freeline Therapeutics (NASDAQ:FRLN) vs. Fate Therapeutics (NASDAQ:FATE) Financial Analysis

Fate Therapeutics (NASDAQ:FATE – Get Rating) and Freeline Therapeutics (NASDAQ:FRLN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Analyst Ratings This is a summary of recent recommendations […] ....

United Kingdom , San Diego , United States , David Scadden , Johnd Mendlein , Leonard Zon , Philip Beachy , Alexander Rives , Michael Rudnicki , Rudolf Jaenisch , Scott Wolchko , Freeline Therapeutics Holdings , Fate Therapeutics Inc , Fate Therapeutics , Get Rating , Freeline Therapeutics , Given Freeline Therapeutic , Freeline Therapeutic , Sheng Ding , Therapeutics Holdings , Fate Therapeutics Daily , Nasdaq Fate , Stock Comparison , Stock Analysis ,

Stifel Nicolaus Lowers Freeline Therapeutics (NASDAQ:FRLN) to Hold

Stifel Nicolaus cut shares of Freeline Therapeutics (NASDAQ:FRLN – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday, The Fly reports. They currently have $1.00 price target on the stock, down from their previous price target of $2.00. Freeline Therapeutics Stock Down 4.1 % Freeline […] ....

Stifel Nicolaus , Freeline Therapeutics Holdings , Freeline Therapeutics Company Profile , Renaissance Technologies , Thrivent Financial For Lutherans , Asset Management Gp Ltd , Hermes Inc , Freeline Therapeutics , Get Rating , Therapeutics Stock Down , Federated Hermes , Therapeutics Holdings , Freeline Therapeutics Daily , Nasdaq Frln ,

Freeline Therapeutics Holdings plc Expected to Earn Q1 2023 Earnings of ($0.25) Per Share (NASDAQ:FRLN)

Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Get Rating) – Stock analysts at HC Wainwright issued their Q1 2023 earnings estimates for Freeline Therapeutics in a report released on Wednesday, April 5th. HC Wainwright analyst P. Trucchio forecasts that the company will earn ($0.25) per share for the quarter. HC Wainwright has a “Buy” rating and […] ....

Stifel Nicolaus , Hermes Inc , Thrivent Financial For Lutherans , Acadian Asset Management , Freeline Therapeutics Company Profile , Freeline Therapeutics Holdings , Asset Management Gp Ltd , Renaissance Technologies , Get Rating , Freeline Therapeutics , Freeline Therapeutic , Asset Management , Therapeutics Holdings , Freeline Therapeutics Daily , Nasdaq Frln , Earnings Estimates , Hc Wainwright ,